Found: 37
Select item for more details and to access through your institution.
Commentary on 'case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2009, v. 18, n. 12, p. 1244, doi. 10.1002/pds.1840
- By:
- Publication type:
- Article
A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14 237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 8, p. 769, doi. 10.1002/pds.1615
- By:
- Publication type:
- Article
The drug interaction potential of daprodustat when coadministered with pioglitazone, rosuvastatin, or trimethoprim in healthy subjects.
- Published in:
- Pharmacology Research & Perspectives, 2018, v. 6, n. 2, p. 1, doi. 10.1002/prp2.327
- By:
- Publication type:
- Article
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-na ïve type 2 diabetes mellitus patients
- Published in:
- Diabetes, Obesity & Metabolism, 2011, v. 13, n. 11, p. 1036, doi. 10.1111/j.1463-1326.2011.01461.x
- By:
- Publication type:
- Article
Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 6, p. 643, doi. 10.1111/j.1463-1326.2006.00648.x
- By:
- Publication type:
- Article
Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2006, v. 8, n. 6, p. 650, doi. 10.1111/j.1463-1326.2006.00659.x
- By:
- Publication type:
- Article
Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Anemia and mortality in patients with nondialysis-dependent chronic kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 8, p. 1890, doi. 10.1093/ndt/gfac342
- By:
- Publication type:
- Article
ASCEND-ND trial: study design and participant characteristics.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2157, doi. 10.1093/ndt/gfab318
- By:
- Publication type:
- Article
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 960, doi. 10.1093/ndt/gfab065
- By:
- Publication type:
- Article
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 7, p. 739, doi. 10.1002/cpdd.1257
- By:
- Publication type:
- Article
Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 562, doi. 10.1002/cpdd.1090
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1419, doi. 10.1002/cpdd.1029
- By:
- Publication type:
- Article
A Randomized, Placebo‐ and Positive‐Controlled, Single‐Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 6, p. 627, doi. 10.1002/cpdd.342
- By:
- Publication type:
- Article
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
- Published in:
- American Journal of Nephrology, 2023, v. 54, n. 1/2, p. 1, doi. 10.1159/000528696
- By:
- Publication type:
- Article
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
- Published in:
- American Journal of Nephrology, 2021, v. 52, n. 1, p. 26, doi. 10.1159/000513103
- By:
- Publication type:
- Article
Posttranslational modification of ras proteins: Detection of a modification prior to fatty acid acylation and cloning of a gene responsible for the modification.
- Published in:
- Journal of Cellular Biochemistry, 1988, v. 36, n. 3, p. 261, doi. 10.1002/jcb.240360307
- By:
- Publication type:
- Article
Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction-induced injury.
- Published in:
- Skeletal Muscle, 2018, v. 8, n. 1, p. N.PAG, doi. 10.1186/s13395-018-0179-5
- By:
- Publication type:
- Article
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 6, p. 1065, doi. 10.1111/1744-9987.13839
- By:
- Publication type:
- Article
Efficacy and safety of daprodustat in Japanese peritoneal dialysis patients.
- Published in:
- Therapeutic Apheresis & Dialysis, 2021, v. 25, n. 6, p. 979, doi. 10.1111/1744-9987.13686
- By:
- Publication type:
- Article
A 24‐Week Anemia Correction Study of Daprodustat in Japanese Dialysis Patients.
- Published in:
- Therapeutic Apheresis & Dialysis, 2020, v. 24, n. 2, p. 108, doi. 10.1111/1744-9987.12962
- By:
- Publication type:
- Article
GlaxoSmithKline responds to the consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 5, p. 693, doi. 10.1093/ckj/sfz013
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 139, doi. 10.1093/ckj/sfy014
- By:
- Publication type:
- Article
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.
- Published in:
- Clinical Kidney Journal, 2019, v. 12, n. 1, p. 129, doi. 10.1093/ckj/sfy013
- By:
- Publication type:
- Article
Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy.
- Published in:
- Diabetes & Vascular Disease Research, 2006, v. 3, n. 3, p. 189, doi. 10.3132/dvdr.2006.029
- By:
- Publication type:
- Article
A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Response to Nathan et al.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes.
- Published in:
- Diabetes Care, 2009, v. 32, n. 5, p. e58, doi. 10.2337/dc09-0125
- By:
- Publication type:
- Article
Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 2, p. 345, doi. 10.2337/diacare.29.02.06.dc05-1626
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- BMC Nephrology, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12882-015-0138-x
- By:
- Publication type:
- Article
Characterization of chronic and acute ESA hyporesponse: a retrospective cohort study of hemodialysis patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article